Repertaxin

Repertaxin · Dompé Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Repertaxin, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation [Phase 2]